Country: United Kingdom
Language: English
Source: VMD (Veterinary Medicines Directorate)
Moxidectin
Zoetis UK Limited
QP54AB02
Moxidectin
Oral gel
POM-VPS -Prescription Only Medicine – Veterinarian, Pharmacist, Suitably Qualified Person
Horses
Endectocide
Expired
2012-07-18
Revised: June 2014 AN: 01740/2013 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Moxiquest 18.92 mg/g Oral Gel for Horses & Ponies 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 1 g contains: ACTIVE SUBSTANCE: Moxidectin 18.92 mg EXCIPIENTS: Benzyl alcohol 37.84 mg Disodium Edetate 0.24 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Oral gel Yellow gel 4. CLINICAL PARTICULARS 4.1. TARGET SPECIES Horses and ponies. 4.2. INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES The veterinary medicinal product is indicated for treatment of infections caused by moxidectin sensitive strains of: Large strongyles: _Strongylus vulgaris_ (adults and arterial stages) _Strongylus edentatus_ (adults and visceral stages) _Triodontophorus brevicauda_ (adults) _Triodontophorus serratus_ (adults) _Triodontophorus tenuicollis _ (adults) Small strongyles (adults and intraluminal larval stages): _Cyathostomum _spp. _Cylicocyclus _spp_._ _Cylicostephanus _spp_._ _Cylicodontophorus_ spp. _Gyalocephalus _spp. Ascarids: _Parascaris equorum_ (adult and larval stages) Revised: June 2014 AN: 01740/2013 Page 2 of 5 Other species: _Oxyuris equi _(adult and larval stages) _Habronema muscae _(adults) _Gasterophilus intestinalis _(L2, L3) _Gasterophilus nasalis _(L2, L3) _Strongyloides westeri _(adults) _Trichostrongylus axei_ The veterinary medicinal product has a persistent efficacy of two weeks against small strongyles. The excretion of small strongyles eggs is suppressed for 90 days. The veterinary medicinal product is effective against (developing) intramucosal L4 stages of small strongyles. At 8 weeks after treatment, early (hypobiotic) EL3 stages of small strongyles are eliminated. 4.3. CONTRAINDICATIONS Do not administer to young foals less than 4 months. Do not administer in cases of known hypersensitivity to the active ingredient or to any other milbemycins and to any other ingredients of the veterina Read the complete document